- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 35.69M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 35.21M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 31.54M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$2.31M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$3.65M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $13.27M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $15.66M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $11.69M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $14.5M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $10.23M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $13.4M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.98M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.54M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3.67M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.27M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $13.85M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $16.28M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $15.36M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $17.77M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.10 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.11 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.10 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.11 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $1.03M |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $1.08M |
| Rd Expense | Q1 2025 · Mar 31, 2025 | $2.26M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $2.41M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$3.19M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$3.51M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$3.33M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$3.61M |